Skip to main content

AMKOR TECHNOLOGY INC

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

AMKR$35.00+6.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed, on its behalf by the undersigned, thereunto duly authorized.

By:/s/ Guillaume Marie Jean Rutten
Guillaume Marie Jean RuttenPresident and Chief Executive Officer
Date:February 16, 2024

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Guillaume Marie Jean Rutten and Megan Faust, and each of them, his or her attorneys-in-fact, and agents, each with the power of substitution, for and in the name, place and stead of such person, in any and all capacities, to sign any and all amendments to this Form 10-K, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and conforming all that said attorneys-in-fact and agents of any of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NameTitleDate
/s/ Guillaume Marie Jean RuttenPresident and Chief Executive OfficerFebruary 16, 2024
Guillaume Marie Jean Rutten(Principal Executive Officer)
/s/ Megan FaustExecutive Vice President, Chief Financial Officer, and TreasurerFebruary 16, 2024
Megan Faust(Principal Financial Officer and Principal Accounting Officer)
/s/ James J. KimExecutive ChairmanFebruary 16, 2024
James J. Kim
/s/ Susan Y. KimExecutive Vice ChairmanFebruary 16, 2024
Susan Y. Kim
/s/ Douglas A. AlexanderDirectorFebruary 16, 2024
Douglas A. Alexander
/s/ Roger A. CarolinDirectorFebruary 16, 2024
Roger A. Carolin
NameTitleDate
/s/ Winston J. ChurchillDirectorFebruary 16, 2024
Winston J. Churchill
/s/ Daniel LiaoDirectorFebruary 16, 2024
Daniel Liao
/s/ MaryFrances McCourtDirectorFebruary 16, 2024
MaryFrances McCourt
/s/ Robert R. MorseDirectorFebruary 16, 2024
Robert R. Morse
/s/ Gil C. TilyDirectorFebruary 16, 2024
Gil C. Tily
/s/ David N. WatsonDirectorFebruary 16, 2024
David N. Watson
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.